Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative C…

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the ...
The Financial

Roche: Phase III ATLAS study achieves a new milestone in treating advanced lung cancer

The FINANCIAL — Roche announced on May 30 that the Phase III ATLAS study showed patients with advanced non-small cell lung cancer (NSCLC) who received Avastin (bevacizumab) and Tarceva (erlotinib) as ...
New York Post

3I/ATLAS will be visible to Earthlings this week — here’s your complete watch guide

Here’s how to keep your 3I on it. With 3I/ATLAS slated to make its Earth tour in two days, amateur photographers and astronomers alike are scrambling to catch sight of the interstellar comet. Our ...